Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma100
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype38
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD35
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma35
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns29
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease26
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
HBV Biomarkers and Their Role in Guiding Treatment Decisions23
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease23
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis22
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury18
Wilson Disease: Novel Diagnostic and Therapeutic Approaches17
Diagnosis and Management of Early Stages of ALD16
Mice Engrafted with Human Liver Cells16
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective15
Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates14
13
Liver Neurobiology: Regulation of Liver Functions by the Nervous System12
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure12
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases11
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure11
11
Role of Complement in Liver Diseases11
Patient-Centered Treatment of Cirrhosis10
Novel Biomarkers of AKI in Cirrhosis10
Hepatocellular Carcinoma Chemoprevention with Generic Agents10
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy10
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future10
Endoscopic Advances in Hepatology10
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology10
10
Mesenchymal Stem Cell Transplantation in Liver Diseases10
Management of Portal vein Thrombosis in Cirrhosis10
Hepatitis Delta Infection: A Clinical Review10
Combined Hepatocellular-Cholangiocarcinoma: A Clinical and Molecular Review10
Optimizing Liver Cancer Care Through BCLC Principles9
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology9
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency9
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD9
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease9
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease9
0.04937481880188